Moneycontrol
HomeNewsBusinessInterview | General insurance poised to grow with economy, medical inflation needs tracking: Tapan Singhel, Bajaj Allianz General Insurance
Trending Topics

Interview | General insurance poised to grow with economy, medical inflation needs tracking: Tapan Singhel, Bajaj Allianz General Insurance

Bajaj Allianz General Insurance’s Tapan Singhel talks about his outlook on the industry, pricing on health and motor insurance, and growth.

September 01, 2021 / 15:20 IST
Story continues below Advertisement
Tapan Singhel, MD & CEO, Bajaj Allianz General Insurance

Even as the economy is ravaged by a deadly pandemic, leading private general insurer, Bajaj Allianz General Insurance is finding opportunities in a crisis-hit market.

In an exclusive interview with Moneycontrol on September 1, Tapan Singhel, Managing Director and Chief Executive Officer of Bajaj Allianz General Insurance said the company is set to grow with multi-product, multi-channel and all geography strategy.

Story continues below Advertisement

Singhel spoke about his outlook on the general insurance space, on how the government and insurance companies can work together on Natural Catastrophes insurance and how the COVID-19 second wave has impacted the insurance sector.

He also highlighted how digital investments have benefited the sector and the rationale behind increase in prices of health insurance. Edited Excerpts:

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show